VTS-270
5,10,15,20,25,30,35-heptakis(2-hydroxypropoxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontane-36,37,38,39,40,41,42,43,44,45,46,47,48,49-tetradecol
Molecular Identity
VTS-270
5,10,15,20,25,30,35-heptakis(2-hydroxypropoxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontane-36,37,38,39,40,41,42,43,44,45,46,47,48,49-tetradecol
PubChem CID: 4363642
2D Structure
Properties
C63H112O42
Molecular Formula
1541.50
Molecular Weight
g/mol
1540.6628
Exact Mass
Da
-13
XLogP
Drug-like (Lipinski: < 5)
619
TPSA
May have limited oral absorption
21
H-Bond Donors
42
H-Bond Acceptors
2010
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(12)
VTS-270RefChem:1101031Trappsol Cyclo107745-73-3(2-Hydroxypropyl)-|A-cyclodextrin5,10,15,20,25,30,35-heptakis(2-hydroxypropoxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontane-36,37,38,39,40,41,42,43,44,45,46,47,48,49-tetradecol6A,6B,6C,6D,6E,6F,6G-Heptakis-O-(2-hydroxypropyl)-beta-cyclodextrinC63H112O42SCHEMBL19239855(2-Hydroxypropyl)-b-cyclodextrin(2-Hydroxypropyl)-?-cyclodextrinMFCD00074978
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to VTS-270
Loading drug network...